C17H19NO4
Neat
301.34
3-Epicrinamine; (+)-Haemanthamine; Natalensine; Hemanthamine; Natalensin; Hemeanthamin; 4abeta, 5alpha, 11balpha-Crinan-12-ol, 1, 2-didehydro-3beta-methoxy-, (12R)-; NSC 403140; Crinan-11-ol, 1, 2-didehydro-3-methoxy-, (3beta, 5alpha, 11R, 13beta, 19alpha)-; 3Epicrinamine; RefChem:783500; 4abeta, 5alpha, 11balphaCrinan12ol, 1, 2didehydro3betamethoxy, (12R); 4abeta, 5alpha, 11balphaCrinan12ol, 1, 2didehydro3betamethoxy, (12R) (8CI); Crinan11ol, 1, 2didehydro3methoxy, (3beta, 5alpha, 11R, 13beta, 19alpha); 4abeta, 5alpha, 11balpha-Crinan-12-ol, 1, 2-didehydro-3beta-methoxy-, (12R)-(8CI); Crinan-11-ol, 1, 2-didehydro-3-methoxy-, (3beta, 5alpha, 11R, 13beta, 19alpha)-(9CI); Crinan11ol, 1, 2didehydro3methoxy, (3beta, 5alpha, 11R, 13beta and 19alpha) (9CI); Haemanthamine; 466-75-1; Haemanthamin
(1S, 13S, 15S, 18R)-15-methoxy-5, 7-dioxa-12-azapentacyclo[10.5.2.01, 13.02, 10.04, 8]nonadeca-2, 4(8), 9 and 16-tetraen-18-ol
InChI=1S/C17H19NO4/c1-20-11-2-3-17-12-6-14-13(21-9-22-14)4-10(12)7-18(8-16(17)19)15(17)5-11/h2-4,6,11,15-16,19H,5,7-9H2,1H3/t11-,15+,16+,17+/m1/s1